rs1329170357
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033087.4(ALG2):c.10G>A(p.Glu4Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,588,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E4E) has been classified as Likely benign.
Frequency
Consequence
NM_033087.4 missense
Scores
Clinical Significance
Conservation
Publications
- polycystic liver disease 1Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- SEC61B-related polycystic liver diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_033087.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG2 | NM_033087.4 | MANE Select | c.10G>A | p.Glu4Lys | missense | Exon 1 of 2 | NP_149078.1 | ||
| ALG2 | NR_024532.2 | n.58G>A | non_coding_transcript_exon | Exon 1 of 3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG2 | ENST00000476832.2 | TSL:1 MANE Select | c.10G>A | p.Glu4Lys | missense | Exon 1 of 2 | ENSP00000417764.1 | ||
| ALG2 | ENST00000238477.5 | TSL:2 | n.10G>A | non_coding_transcript_exon | Exon 1 of 3 | ENSP00000432675.2 | |||
| SEC61B | ENST00000498603.5 | TSL:3 | c.-446C>T | upstream_gene | N/A | ENSP00000474122.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.0000111 AC: 16AN: 1435786Hom.: 0 Cov.: 32 AF XY: 0.0000112 AC XY: 8AN XY: 713352 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74386 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 4 of the ALG2 protein (p.Glu4Lys). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ALG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 533477). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at